Table 1 Part 1. Patient characteristics and associations with inflammatory response after cardiopulmonary bypass
Variables | Inflammatory response (n = 34) | No inflammatory response (n = 131) | P value |
|---|---|---|---|
Age, years | 61 ± 12 | 61 ± 13 | 0.97 |
Gender | Â | Â | Â |
   Male, number (percentage) | 24 (70) | 88 (67) | 0.70 |
   Female, number (percentage) | 10 (30) | 43 (33) | 0.70 |
Body mass index, kg/m2 | 28.5 ± 5 | 27.5 ± 4.2 | 0.20 |
Parsonnet score | 13.6 ± 9.2 | 12.1 ± 6.8 | 0.35 |
Comorbidity | Â | Â | Â |
   Renal disease, number (percentage) | 4 (11) | 8 (6) | 0.26 |
   Diabetic status, number (percentage) | 12 (35) | 44 (34) | 0.85 |
   Angiotensin-converting enzyme inhibitors, number (percentage) | 10 (29) | 45 (34) | 0.58 |
Cardiac intervention | Â | Â | Â |
   Coronary, number (percentage) | 19 (56) | 81 (62) | 0.20 |
   Valvular, number (percentage) | 9 (26) | 41 (31) | 0.58 |
   Both, number (percentage) | 6 (17) | 9 (7) | 0.051 |
   Reintervention, number (percentage) | 2 (6) | 6 (5) | 0.75 |
Surgical data | Â | Â | Â |
   Total cardiopulmonary bypass time, minutes | 101 ± 33 | 93 ± 33 | 0.20 |
   Aortic clamping time, minutes | 61.6 ± 27.3 | 54 ± 22.8 | 0.11 |
   Tranexamic acid, number (percentage) | 8 (26) | 78 (60) | <0.01 |
   No antifibrinolytics, number (percentage) | 26 (76) | 53 (40) | 0.44 |
   Intensive care unit stay, days | 7.8 ± 6.4 | 3.2 ± 1.7 | <0.01 |
   Hospital stay, days | 17.6 ± 20.5 | 9.1 ± 6.2 | <0.01 |